{"slug":"tesamorelin-insomnia","verification":{"valid":true,"entries":2,"head":"d0dacec9e9c97681ba9fddc6c8276a80dd6feea0121edd0f15d302f8c6e45da8"},"energy":{"passes":2,"tokens_in":13475,"tokens_out":2499,"tokens_total":15974,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"d0dacec9e9c97681ba9fddc6c8276a80dd6feea0121edd0f15d302f8c6e45da8"},"provenance":[{"ts":"2026-06-29T23:20:04.031Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tesamorelin for Insomnia\nSlug: tesamorelin-insomnia\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tesamorelin\",\"name\":\"Tesamorelin\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tesamorelin\",\"name\":\"Tesamorelin\",\"section_title\":\"Why Tesamorelin might help you\",\"layer\":\"GH axis / visceral fat\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Tesamorelin** → GH axis / visceral fat\",\"section_headings\":[\"What's breaking down\",\"Why Tesamorelin might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide es","response":"{\n  \"slug\": \"tesamorelin-insomnia\",\n  \"title\": \"Tesamorelin for Insomnia: Evidence Review\",\n  \"body\": \"## What's breaking down\\n\\nInsomnia involves disrupted sleep architecture, reduced slow-wave sleep, and impaired overnight repair processes. Growth hormone release normally peaks during deep sleep stages. Declines in this axis or excess visceral fat can fragment sleep and blunt recovery signals. Tesamorelin targets the GH axis directly rather than suppressing symptoms.\\n\\n## Why Tesamorelin might help you\\n\\n1. **Therefore for you:** If GH axis decline contributes to your fragmented sleep, Tesamorelin is discussed because it stimulates endogenous pulsatile GH release aligned with natural nighttime peaks.\\n2. **Therefore for you:** If visceral fat load interferes with sleep continuity, Tesamorelin is discussed because it reduces visceral adipose tissue in studied populations, which may ease mechanical or metabolic strain on rest.\\n3. **Therefore for you:** If your problem centers on tissue repair outpacing breakdown during sleep, Tesamorelin is discussed because it amplifies GH/IGF-1 pathways linked to overnight regeneration rather than masking wakefulness.\\n\\n## How these fit together\\n\\nSingle-compound focus. Tesamorelin addresses the GH axis and visceral fat layer. If your profile includes other degeneration layers, additional compounds would target them separately without overlap.\\n\\n## What the evidence actually shows\\n\\nNo completed human trials specifically test Tesamorelin for insomnia treatment. Early development documents noted phase II exploration for sleep maintenance insomnia, but results are not publicly detailed and the compound advanced for HIV lipodystrophy instead. Human trials in HIV patients show visceral fat reduction and increased overnight GH but do not report primary sleep outcome measures. Side-effect listings from regulatory sources include insomnia and trouble sleeping in 1-10% of participants. Preclinical or mechanistic data link GHRH ana","tokens_in":13475,"tokens_out":2499,"cost":0,"prev":"genesis","hash":"a4abe6f5cf6b8f495dcd10f8c61ca2f0878c06277140a17b216b21eec6adf87a"},{"ts":"2026-07-17T02:42:23.712Z","model":"owner","action":"voxel_divide","prompt":"","input":"tesamorelin-insomnia","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"a4abe6f5cf6b8f495dcd10f8c61ca2f0878c06277140a17b216b21eec6adf87a","hash":"d0dacec9e9c97681ba9fddc6c8276a80dd6feea0121edd0f15d302f8c6e45da8"}]}